Brazilian (BOVESPA) Drug Retail Industry Analysis
UpdatedApr 19, 2024
DataAggregated Company Financials
Companies4
- 7D-5.4%
- 3M-8.0%
- 1Y1.5%
- YTDn/a
The Drug Retail industry has been flat over the last week, but Empreendimentos Pague Menos has lost 4.4%. As for the the longer term, the industry is up 5.3% over the past 12 months. Looking forward, earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the Brazilian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 20 Apr 2024 | R$46.2b | R$51.4b | R$1.2b | 29.4x | 39.5x | 0.9x |
| Mon, 18 Mar 2024 | R$49.9b | R$51.4b | R$1.2b | 31.5x | 42.7x | 1x |
| Wed, 14 Feb 2024 | R$47.1b | R$49.8b | R$1.1b | 20.4x | 44.5x | 0.9x |
| Fri, 12 Jan 2024 | R$53.4b | R$49.8b | R$1.1b | 21.9x | 50.4x | 1.1x |
| Sun, 10 Dec 2023 | R$52.3b | R$49.8b | R$1.1b | 20.9x | 49.4x | 1.1x |
| Tue, 07 Nov 2023 | R$46.9b | R$49.3b | R$997.0m | 19.7x | 47.1x | 1x |
| Thu, 05 Oct 2023 | R$50.2b | R$48.1b | R$948.8m | 20.8x | 52.9x | 1x |
| Sat, 02 Sep 2023 | R$51.1b | R$48.1b | R$948.8m | 22.2x | 53.8x | 1.1x |
| Mon, 31 Jul 2023 | R$53.9b | R$46.0b | R$1.1b | 23.3x | 50.8x | 1.2x |
| Wed, 28 Jun 2023 | R$53.4b | R$46.0b | R$1.1b | 21.6x | 50.3x | 1.2x |
| Fri, 26 May 2023 | R$51.5b | R$46.0b | R$1.1b | 20.3x | 48.5x | 1.1x |
| Sun, 23 Apr 2023 | R$45.1b | R$43.7b | R$1.1b | 16.9x | 41.3x | 1x |
| Tue, 21 Mar 2023 | R$41.8b | R$43.5b | R$1.1b | 16.2x | 38.3x | 1x |
| Thu, 16 Feb 2023 | R$42.0b | R$41.4b | R$1.0b | 30.9x | 41.5x | 1x |
| Sat, 14 Jan 2023 | R$43.1b | R$41.4b | R$1.0b | 31.2x | 42.7x | 1x |
| Mon, 12 Dec 2022 | R$42.2b | R$41.4b | R$1.0b | 30.8x | 41.8x | 1x |
| Wed, 09 Nov 2022 | R$48.5b | R$40.5b | R$1.1b | 22.1x | 43.7x | 1.2x |
| Fri, 07 Oct 2022 | R$44.1b | R$39.2b | R$1.0b | 21.9x | 42x | 1.1x |
| Sun, 04 Sep 2022 | R$41.5b | R$39.2b | R$1.0b | 20x | 39.6x | 1.1x |
| Tue, 02 Aug 2022 | R$39.8b | R$38.7b | R$1.0b | 32.6x | 38x | 1x |
| Thu, 30 Jun 2022 | R$35.2b | R$37.4b | R$945.0m | 30.8x | 37.2x | 0.9x |
| Sat, 28 May 2022 | R$39.0b | R$37.3b | R$943.7m | 35x | 41.3x | 1x |
| Mon, 25 Apr 2022 | R$42.7b | R$36.0b | R$997.8m | 36x | 42.8x | 1.2x |
| Wed, 23 Mar 2022 | R$43.5b | R$35.9b | R$997.3m | 37.6x | 43.7x | 1.2x |
| Fri, 18 Feb 2022 | R$45.1b | R$34.8b | R$1.0b | 31.6x | 44.7x | 1.3x |
| Sun, 16 Jan 2022 | R$40.0b | R$34.8b | R$1.0b | 30.5x | 39.7x | 1.1x |
| Tue, 14 Dec 2021 | R$45.5b | R$34.8b | R$1.0b | 37.1x | 45.1x | 1.3x |
| Thu, 11 Nov 2021 | R$46.7b | R$33.6b | R$1.0b | 31x | 45.9x | 1.4x |
| Sat, 09 Oct 2021 | R$45.8b | R$33.5b | R$1.0b | 33.3x | 44.8x | 1.4x |
| Mon, 06 Sep 2021 | R$51.7b | R$33.5b | R$1.0b | 36.7x | 50.6x | 1.5x |
| Wed, 04 Aug 2021 | R$50.8b | R$33.5b | R$1.0b | 44.8x | 49.8x | 1.5x |
| Sat, 08 May 2021 | R$51.1b | R$31.6b | R$726.3m | 48.1x | 70.4x | 1.6x |
Price to Earnings Ratio
70.4x
Current Industry PE
- Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 41.7x which is lower than its 3-year average PE of 46.3x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.95x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 18% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Brazilian Drug Retail compare with similar industries?
| BR Market | -1.62% | |
| Consumer Staples | -2.18% | |
| Food and Staples Retail | -6.22% | |
| Drug Retail | -5.38% | |
| Food Distributors | 0% | |
| Big Box Super Stores | -6.85% | |
| Food Retail | -7.45% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DMVF3 d1000 Varejo Farma Participações | R$8.17 | 17.0% +R$60.2m | 141.0% | PE19.4x | |
| PGMN3 Empreendimentos Pague Menos | R$2.67 | 2.7% +R$40.5m | 2.3% | PE7058x |